Comparison between familial and sporadic cutaneous melanoma in Valencia, Spain

Journal of the European Academy of Dermatology and Venereology

Volumn 22, Issue 8, 2008, Pages 931-936

  Nagore, E ^a   Botella Estrada, R ^a   Garcia Casado, Z ^a   Requena, C ^a   Serra Guillen, C ^a   Llombart, B ^a   Sanmartin, O ^a   Guillen, C ^a  

^a INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

Author keywords

Clinical; Familial; Melanoma; Risk factors

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; FAMILIAL CUTANEOUS MELANOMA; FEMALE; GENETIC RISK; GENETIC SUSCEPTIBILITY; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; SPAIN; SPORADIC CUTANEOUS MELANOMA; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS;

ADULT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MELANOMA; MIDDLE AGED; PHENOTYPE; REGRESSION ANALYSIS; RISK FACTORS; SKIN NEOPLASMS; SPAIN;

EID: 52249113326     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2008.02682.x     Document Type: Article

References (24)

1. Ang CG, Kelly JW, Fritschi L, Dowling JP. Characteristics of familial and non-familial melanoma in Australia. Melanoma Res 1998 8 : 459 464.
2. Hemminki K, Lonnstedt I, Vaittinen P. A population-based study of familial cutaneous melanoma. Melanoma Res 2001 11 : 133 140.
3. Gandini S, Sera F, Cattaruzza MS et al. Meta-analysis of risk factors for cutaneous melanoma. III. Family history, actinic damage and phenotypic factors. Eur J Cancer 2005 41 : 2040 2059.
4. Barnhill RL, Roush GC, Titus-Ernstoff L, Ernstoff MS, Duray PH, Kirkwood JM. Comparison of nonfamilial and familial melanoma. Dermatology 1992 184 : 2 7.
5. Lucchina LC, Barnhill RL, Duke DM, Sober AJ. Familial cutaneous melanoma. Melanoma Res 1995 5 : 413 418.
6. Kopf AW, Hellman LJ, Rogers GS et al. Familial malignant melanoma. JAMA 1986 256 : 1915 1919.
7. Anderson DE. Clinical characteristics of the genetic variety of cutaneous melanoma in man. Cancer 1971 28 : 721 725.
8. Wallace DC, Beardmore GL, Exton LA. Familial malignant melanoma. Ann Surg 1973 177 : 15 20.
9. Florell SR, Boucher KM, Garibotti G et al. Population-based analysis of prognostic factors and survival in familial melanoma. J Clin Oncol 2005 23 : 7168 7177.
10. Grange F, Chompret A, Guilloud-Bataille M et al. Comparison between familial and nonfamilial melanoma in France. Arch Dermatol 1995 131 : 1154 1159.
11. Greene MH, Clark WH Jr., Tucker MA, Kramer KH, Elder DE, Fraser MC. High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med 1985 102 : 458 465.
12. Whiteman DC, Parsons PG, Green AC. p53 expression and risk factors for cutaneous melanoma: a case-control study. Int J Cancer 1998 77 : 843 848.
13. Whiteman DC, Watt P, Purdie DM, Hughes MC, Hayward NK, Greene AC. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst 2003 95 : 806 812.
14. Curtin JA, Fridlyand J, Kageshita T et al. Distinct sets of genetic alterations in melanoma. N Engl J Med 2005 353 : 2135 2147.
15. Gandini S, Sera F, Cattaruzza MS et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer 2005 41 : 28 44.
16. Aitken JF, Youl P, Green A, MacLennan R, Martin NG. Accuracy of case-reported family history of melanoma in Queensland, Australia. Melanoma Res 1996 6 : 313 317.
17. Aitken JF, Duffy DL, Green A, Youl P, MacLennan R, Martin NG. Heterogeneity of melanoma risk in families of melanoma patients. Am J Epidemiol 1994 140 : 961 973.
18. Pollock PM, Weeraratna A, Trent JM. Genetics and molecular staging. In : Balch CM, Houghton AN, Sober AJ et al., eds. Cutaneous Melanoma, 4th edn. Quality Medical Publishing, Inc., St. Louis, MO, 2003 : 687 712.
19. Newton JA, Bataille V, Griffiths K et al. How common is the atypical mole syndrome phenotype in apparently sporadic melanoma? J Am Acad Dermatol 1993 29 : 989 996.
20. Vasen HF, Gruis NA, Frants RR, van der Velden PA, Hille ET, Bergman W. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). Int J Cancer 2000 87 : 809 811.
21. Goldstein AM, Chan M, Harland M et al. Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J Med Genet 2007 44 : 99 106.
22. Puig S, Malvehy J, Badenas C et al. Role of the CDKN2A locus in patients with multiple primary melanomas. J Clin Oncol 2005 23 : 3043 3051.
23. Newton JA. Familial melanoma. Clin Exp Dermatol 1993 18 : 5 11.
24. Garbe C, Buttner P, Weiss J et al. Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: multicenter case-control study of the central malignant melanoma registry of the German Dermatological Society. J Invest Dermatol 1994 102 : 700 705.